Biological Background of IL-24

Interleukin-24 (IL-24), also known as melanoma differentiation-associated gene 7 (MDA-7), is a pleiotropic cytokine belonging to the IL-10 family of cytokines. It signals through two heterodimeric receptor complexes: IL-20Rα/IL-20Rβ and IL-22Rα1/IL-20Rβ, activating downstream JAK-STAT signaling pathways, particularly STAT1 and STAT3.

IL-24 exhibits a unique dual role: it functions as a pro-inflammatory and immunomodulatory cytokine in normal tissue homeostasis, while demonstrating potent tumor-suppressive activities selectively in cancer cells. It can induce apoptosis, inhibit angiogenesis, and suppress tumor growth without affecting normal cells, making it a subject of significant interest in oncology research.

IL-24 is expressed by a variety of immune cells including monocytes, macrophages, dendritic cells, T helper 2 (Th2) cells, and mast cells. Its expression has been studied in the context of wound healing, psoriasis, cancer, and autoimmune diseases.

Reconstitution and Handling Protocol

Proper reconstitution and handling of Recombinant Human IL24 Protein (rp368362) is critical for maintaining biological activity and experimental reproducibility. Follow the steps below:

1. Equilibration: Allow the vial to equilibrate to room temperature for 10–15 minutes before opening to minimize condensation and protein aggregation.
2. Reconstitution: Reconstitute lyophilized IL-24 protein in sterile, endotoxin-free water or an appropriate buffer (e.g., PBS containing 0.1% BSA) to a stock concentration typically between 0.1–1.0 mg/mL. Refer to the specific product datasheet for the recommended reconstitution volume.
3. Gentle mixing: Do not vortex. Gently swirl or pipette up and down to dissolve. Allow 10 minutes for complete dissolution.
4. Aliquoting: Prepare single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which degrade protein activity.
5. Storage after reconstitution: Store reconstituted protein at 4°C for short-term use (up to 7 days) or at -20°C to -80°C for longer periods. Addition of a carrier protein such as 0.1% BSA is recommended for dilute solutions.

Note: Always consult the product-specific datasheet supplied with SKU rp368362 for exact reconstitution instructions, as conditions may vary by lot.

Research Applications

Recombinant Human IL24 Protein (rp368362) is suitable for a range of in vitro and in vivo research applications:

• Apoptosis and cancer biology: IL-24 is widely used to study its selective pro-apoptotic effects in human cancer cell lines (e.g., breast, lung, prostate, melanoma) while sparing normal cells. It can be used in cell viability, caspase activation, and annexin V apoptosis assays.
• Cytokine signaling studies: Suitable for investigating JAK1/TYK2-mediated STAT1/STAT3 phosphorylation downstream of IL-20Rα/β and IL-22Rα1/IL-20Rβ receptor complexes.
• Angiogenesis research: IL-24 has been reported to inhibit VEGF expression and tumor angiogenesis; recombinant protein can be applied in endothelial tube formation and migration assays.
• Immunology and inflammation: Use in assays measuring cytokine production, dendritic cell maturation, or T-cell polarization in the context of wound healing, psoriasis models, or autoimmune research.
• Bioassay standard: Can be used as a positive control or standard in ELISA-based detection of IL-24 in biological samples.

Always validate working concentrations empirically, as optimal doses vary by cell type and assay format.

Quality, Purity, and Safety Considerations

When selecting and using Recombinant Human IL24 Protein for critical research applications, consider the following quality parameters:

• Purity: Research-grade recombinant cytokines are typically produced with >95% purity as determined by SDS-PAGE and/or HPLC. Verify the certificate of analysis (CoA) for lot-specific purity data for rp368362.
• Endotoxin levels: Endotoxin contamination can confound cytokine signaling and immune cell assays. Confirm that endotoxin levels meet acceptable thresholds (commonly <1.0 EU/µg) for your application.
• Biological activity: Activity is typically confirmed by a cell-based bioassay (e.g., STAT phosphorylation in responsive cell lines). Review the product datasheet for the reported ED50 value.
• Formulation: The lyophilized formulation offers extended shelf life compared to liquid formats. Confirm excipient composition on the datasheet to ensure compatibility with downstream assays.
• Safety: Handle all recombinant proteins in accordance with institutional biosafety guidelines. Although IL-24 is a human cytokine, treat it as a potential biological hazard. Wear appropriate PPE including gloves and lab coat.